-
1
-
-
78651041767
-
The liver in obesity
-
Zelman S. The liver in obesity. Arch Intern Med 1958, 90:141-156.
-
(1958)
Arch Intern Med
, vol.90
, pp. 141-156
-
-
Zelman, S.1
-
2
-
-
0016630274
-
Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease
-
Peters R.L., Gay T., Reynolds T.B. Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 1975, 63:318-331.
-
(1975)
Am J Clin Pathol
, vol.63
, pp. 318-331
-
-
Peters, R.L.1
Gay, T.2
Reynolds, T.B.3
-
3
-
-
34249668818
-
Epidemiology and natural history of NAFLD and NASH
-
Ong J.P., Younossi Z.M. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007, 11:1-16.
-
(2007)
Clin Liver Dis
, vol.11
, pp. 1-16
-
-
Ong, J.P.1
Younossi, Z.M.2
-
4
-
-
0019152816
-
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
-
Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
-
(1980)
Mayo Clin Proc
, vol.55
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
McGill, D.B.3
-
5
-
-
33645554182
-
Nonalcoholic fatty liver disease and liver transplantation
-
Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 2006, 12:523-534.
-
(2006)
Liver Transpl
, vol.12
, pp. 523-534
-
-
Angulo, P.1
-
6
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
7
-
-
33646852746
-
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
-
Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006, 144:705-714.
-
(2006)
Ann Intern Med
, vol.144
, pp. 705-714
-
-
Armstrong, G.L.1
Wasley, A.2
Simard, E.P.3
-
8
-
-
11144264156
-
Nonalcoholic fatty liver disease: a review of current understanding and future impact
-
Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastro and Hepatol 2004, 2:1048-1058.
-
(2004)
Clin Gastro and Hepatol
, vol.2
, pp. 1048-1058
-
-
Charlton, M.1
-
9
-
-
0025178612
-
The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years
-
Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
-
(1990)
Hepatology
, vol.11
, pp. 74-80
-
-
Powell, E.E.1
Cooksley, W.G.2
Hanson, R.3
-
10
-
-
0032695030
-
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
-
Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356-1362.
-
(1999)
Hepatology
, vol.30
, pp. 1356-1362
-
-
Angulo, P.1
Keach, J.C.2
Batts, K.P.3
-
11
-
-
0036724436
-
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
-
Evans C.D., Oien K.A., MacSween R.N., et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?. J Clin Pathol 2002, 55:689-692.
-
(2002)
J Clin Pathol
, vol.55
, pp. 689-692
-
-
Evans, C.D.1
Oien, K.A.2
MacSween, R.N.3
-
12
-
-
0141794560
-
Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natural history?
-
Ong J.P., Younossi Z.M. Nonalcoholic fatty liver disease (NAFLD)-two decades later: are we smarter about its natural history?. Am J Gastroenterol 2003, 98:1915-1917.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1915-1917
-
-
Ong, J.P.1
Younossi, Z.M.2
-
13
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
-
Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005, 42:132-138.
-
(2005)
J Hepatol
, vol.42
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
-
14
-
-
0141510580
-
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
-
Harrison S.A., Torgerson S., Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003, 98:2042-2047.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2042-2047
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.H.3
-
15
-
-
0035431018
-
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
-
Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
-
(2001)
Diabetes
, vol.50
, pp. 1844-1850
-
-
Marchesini, G.1
Brizi, M.2
Bianchi, G.3
-
16
-
-
53049101877
-
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
-
Aithal G.P., Thomas J.A., Kaye P.V., et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008, 135:1176-1184.
-
(2008)
Gastroenterology
, vol.135
, pp. 1176-1184
-
-
Aithal, G.P.1
Thomas, J.A.2
Kaye, P.V.3
-
17
-
-
75449116707
-
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT 2) extension trial
-
Ratziu V., Charlotte F., Bernhardt C., et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis, results of the Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT 2) extension trial. Hepatology 2010, 51:445-453.
-
(2010)
Hepatology
, vol.51
, pp. 445-453
-
-
Ratziu, V.1
Charlotte, F.2
Bernhardt, C.3
-
18
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006, 355:2297-2307.
-
(2006)
N Engl J Med
, vol.355
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
-
19
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal A., Chalasani N., Kowdley K.V., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010, 362:1675-1685.
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.1
Chalasani, N.2
Kowdley, K.V.3
-
20
-
-
46349088361
-
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial
-
Ratziu V., Giral P., Jacqueminet S., et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial. Gastroenterology 2008, 135:100-110.
-
(2008)
Gastroenterology
, vol.135
, pp. 100-110
-
-
Ratziu, V.1
Giral, P.2
Jacqueminet, S.3
-
21
-
-
74349125502
-
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
-
Omer Z., Cetinkalp S., Akyildiz M., et al. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2010, 22:18-23.
-
(2010)
Eur J Gastroenterol Hepatol
, vol.22
, pp. 18-23
-
-
Omer, Z.1
Cetinkalp, S.2
Akyildiz, M.3
-
22
-
-
34548306770
-
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
-
Lutchman G., Modi A., Kleiner D.E., et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007, 46:424-429.
-
(2007)
Hepatology
, vol.46
, pp. 424-429
-
-
Lutchman, G.1
Modi, A.2
Kleiner, D.E.3
-
23
-
-
34548200442
-
Pioglitazone treatment increases whole body fat but not total body water in patients with nonalcoholic steatohepatitis
-
Balas B., Belfort R., Harrison S.A., et al. Pioglitazone treatment increases whole body fat but not total body water in patients with nonalcoholic steatohepatitis. J Hepatology 2007, 47:565-570.
-
(2007)
J Hepatology
, vol.47
, pp. 565-570
-
-
Balas, B.1
Belfort, R.2
Harrison, S.A.3
-
24
-
-
0026638458
-
Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver
-
Parola M., Muraca R., Dianzani I., et al. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett 1992, 308:267-270.
-
(1992)
FEBS Lett
, vol.308
, pp. 267-270
-
-
Parola, M.1
Muraca, R.2
Dianzani, I.3
-
25
-
-
0033025969
-
Comparisons of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey
-
Strauss R. Comparisons of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J Pediatr 1999, 134:160-165.
-
(1999)
J Pediatr
, vol.134
, pp. 160-165
-
-
Strauss, R.1
-
26
-
-
0034799895
-
Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis, a pilot study
-
Hasegawa T., Yoneda M., Nakamura K., et al. Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis, a pilot study. Aliment Pharmacol Ther 2001, 15:1667-1672.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1667-1672
-
-
Hasegawa, T.1
Yoneda, M.2
Nakamura, K.3
-
27
-
-
33947400987
-
Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with nonalcoholic steatohepatitis, results of a pilot study
-
Yakaryilmaz F., Guliter S., Savas B., et al. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with nonalcoholic steatohepatitis, results of a pilot study. Intern Med J 2007, 37:229-235.
-
(2007)
Intern Med J
, vol.37
, pp. 229-235
-
-
Yakaryilmaz, F.1
Guliter, S.2
Savas, B.3
-
28
-
-
0344742265
-
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
-
Harrison S.A., Torgerson S., Hayashi P., et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003, 98:2485-2490.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2485-2490
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.3
-
29
-
-
33845336554
-
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis
-
Dufour J.F., Oneta C.M., Gonvers J.J., et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2006, 4:1537-1543.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1537-1543
-
-
Dufour, J.F.1
Oneta, C.M.2
Gonvers, J.J.3
-
30
-
-
14944359845
-
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
-
Sanyal A., Mofrad P., Contos M., et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004, 2:1107-1115.
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 1107-1115
-
-
Sanyal, A.1
Mofrad, P.2
Contos, M.3
-
31
-
-
19944427642
-
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality
-
Miller E.R., Pastor-Barriuso R., Dalal D., et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
-
(2005)
Ann Intern Med
, vol.142
, pp. 37-46
-
-
Miller, E.R.1
Pastor-Barriuso, R.2
Dalal, D.3
-
32
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
Zhou G., Myers R., Li Y., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
-
(2001)
J Clin Invest
, vol.108
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
-
33
-
-
38049131878
-
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with nonalcoholic steatohepatitis
-
De Oliveira C.P., Stefano J.D., de Siueira E.R., et al. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with nonalcoholic steatohepatitis. Hepatol Res 2008, 38:159-165.
-
(2008)
Hepatol Res
, vol.38
, pp. 159-165
-
-
De Oliveira, C.P.1
Stefano, J.D.2
de Siueira, E.R.3
-
34
-
-
0035883890
-
Metformin in nonalcoholic steatohepatitis
-
Marchesini G., Brizi M., Bianchi G., et al. Metformin in nonalcoholic steatohepatitis. Lancet 2001, 358:893-894.
-
(2001)
Lancet
, vol.358
, pp. 893-894
-
-
Marchesini, G.1
Brizi, M.2
Bianchi, G.3
-
35
-
-
1642296465
-
Metformin in the treatment of patients with nonalcoholic steatohepatitis
-
Uygun A., Kadayifici A., Isik A.T., et al. Metformin in the treatment of patients with nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2004, 19:537-544.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 537-544
-
-
Uygun, A.1
Kadayifici, A.2
Isik, A.T.3
-
36
-
-
3142670354
-
Metformin in the treatment of nonalcoholic steatohepatitis: a pilot open label trial
-
Nair S., Diehl A.M., Wiseman M., et al. Metformin in the treatment of nonalcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004, 20:23-28.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 23-28
-
-
Nair, S.1
Diehl, A.M.2
Wiseman, M.3
-
37
-
-
57649229536
-
Pilot study of metformin for the treatment of nonalcoholic steatohepatitis
-
Loomba R., Lutchman G., Kleiner D.E., et al. Pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2009, 29:172-182.
-
(2009)
Aliment Pharmacol Ther
, vol.29
, pp. 172-182
-
-
Loomba, R.1
Lutchman, G.2
Kleiner, D.E.3
-
38
-
-
19144365586
-
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
-
Bugianesi E., Gentilcore E., Manini R., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005, 100:1082-1090.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1082-1090
-
-
Bugianesi, E.1
Gentilcore, E.2
Manini, R.3
-
39
-
-
77955470801
-
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
-
Garinis G.A., Fruci B., Mazza A., et al. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes 2010, 34:1255-1264.
-
(2010)
Int J Obes
, vol.34
, pp. 1255-1264
-
-
Garinis, G.A.1
Fruci, B.2
Mazza, A.3
-
40
-
-
0037372390
-
Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study
-
Merat S., Malekzadeh R., Sohrabi M.R., et al. Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol 2003, 36:266-268.
-
(2003)
J Clin Gastroenterol
, vol.36
, pp. 266-268
-
-
Merat, S.1
Malekzadeh, R.2
Sohrabi, M.R.3
-
41
-
-
0037383865
-
Probucol in the treatment of nonalcoholic steatohepatitis: a double-blind randomized controlled study
-
Merat S., Malekzadeh R., Sohrabi M.R., et al. Probucol in the treatment of nonalcoholic steatohepatitis: a double-blind randomized controlled study. J Hepatol 2003, 38:414-418.
-
(2003)
J Hepatol
, vol.38
, pp. 414-418
-
-
Merat, S.1
Malekzadeh, R.2
Sohrabi, M.R.3
-
42
-
-
46449124024
-
Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol
-
Merat S., Aduli M., Kazemi R., et al. Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. Dig Dis Sci 2008, 53:2246-2250.
-
(2008)
Dig Dis Sci
, vol.53
, pp. 2246-2250
-
-
Merat, S.1
Aduli, M.2
Kazemi, R.3
-
43
-
-
11144249271
-
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
-
Adams L.A., Zein C.O., Angulo P., et al. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99:2365-2368.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 2365-2368
-
-
Adams, L.A.1
Zein, C.O.2
Angulo, P.3
-
44
-
-
7044269614
-
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
-
Satapathy S.K., Garg S., Chauhan, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99:1946-1952.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1946-1952
-
-
Satapathy, S.K.1
Garg, S.C.2
-
45
-
-
34247210640
-
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis, and necroinflammation in patients with nonalcoholic steatohepatitis
-
Satapathy S.K., Sakhuja P., Malhotra V., et al. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis, and necroinflammation in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2007, 22:634-638.
-
(2007)
J Gastroenterol Hepatol
, vol.22
, pp. 634-638
-
-
Satapathy, S.K.1
Sakhuja, P.2
Malhotra, V.3
-
46
-
-
69749088832
-
A randomized controlled pilot study of pentoxifylline in patients with nonalcoholic steatohepatitis
-
Lee Y.M., Sutedja D.S., Wai C.T., et al. A randomized controlled pilot study of pentoxifylline in patients with nonalcoholic steatohepatitis. Hepatol Int 2008, 2:196-201.
-
(2008)
Hepatol Int
, vol.2
, pp. 196-201
-
-
Lee, Y.M.1
Sutedja, D.S.2
Wai, C.T.3
-
47
-
-
35349024283
-
Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis
-
Song Z., Deaciuc I., Zhou Z., et al. Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 2007, 293:894-902.
-
(2007)
Am J Physiol Gastrointest Liver Physiol
, vol.293
, pp. 894-902
-
-
Song, Z.1
Deaciuc, I.2
Zhou, Z.3
-
48
-
-
0034834208
-
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study
-
Abdelmalek M.F., Angulo P., Jorgensen R.A., et al. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001, 96:2711-2717.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2711-2717
-
-
Abdelmalek, M.F.1
Angulo, P.2
Jorgensen, R.A.3
-
49
-
-
73149092115
-
Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial
-
Abdelmalek M.F., Sanderson S.O., Angulo P., et al. Betaine for nonalcoholic fatty liver disease, results of a randomized placebo-controlled trial. Hepatology 2009, 50:1818-1826.
-
(2009)
Hepatology
, vol.50
, pp. 1818-1826
-
-
Abdelmalek, M.F.1
Sanderson, S.O.2
Angulo, P.3
-
50
-
-
0034942512
-
The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent
-
Rodrigues C.M., Steer C.J. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. Expert Opin Investig Drugs 2001, 10:1243-1253.
-
(2001)
Expert Opin Investig Drugs
, vol.10
, pp. 1243-1253
-
-
Rodrigues, C.M.1
Steer, C.J.2
-
51
-
-
0031950282
-
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production
-
Rodrigues C.M., Fan G., Wong P.Y., et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998, 4:165-178.
-
(1998)
Mol Med
, vol.4
, pp. 165-178
-
-
Rodrigues, C.M.1
Fan, G.2
Wong, P.Y.3
-
52
-
-
84933047295
-
Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis: a pilot study
-
Laurin J., Lindor K.D., Crippin J.S., et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis: a pilot study. Hepatology 1996, 23:1464-1467.
-
(1996)
Hepatology
, vol.23
, pp. 1464-1467
-
-
Laurin, J.1
Lindor, K.D.2
Crippin, J.S.3
-
53
-
-
1542515099
-
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial
-
Lindor K.D., Kowdley K.V., Heathcote E.J., et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis, results of randomized trial. Hepatology 2004, 39:770-778.
-
(2004)
Hepatology
, vol.39
, pp. 770-778
-
-
Lindor, K.D.1
Kowdley, K.V.2
Heathcote, E.J.3
-
54
-
-
77958100236
-
A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis
-
Adams L.A., Angulo P., Petz J., et al. A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis. Hepatol Int 2010, 4:628-633.
-
(2010)
Hepatol Int
, vol.4
, pp. 628-633
-
-
Adams, L.A.1
Angulo, P.2
Petz, J.3
-
55
-
-
77955699301
-
High-dose ursodeoxycholic acid therapy for the treatment of nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
-
Leuschner U.F., Lindenthal B., Hermann G., et al. High-dose ursodeoxycholic acid therapy for the treatment of nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology 2010, 52:472-479.
-
(2010)
Hepatology
, vol.52
, pp. 472-479
-
-
Leuschner, U.F.1
Lindenthal, B.2
Hermann, G.3
-
56
-
-
79954764140
-
A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis
-
Ratziu V., de Ledinghen V., Oberti F., et al. A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2010, 54:1011-1019.
-
(2010)
J Hepatol
, vol.54
, pp. 1011-1019
-
-
Ratziu, V.1
de Ledinghen, V.2
Oberti, F.3
-
57
-
-
27744490794
-
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
-
Suzuki A., Lindor K., St Saver J., et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005, 43:1060-1066.
-
(2005)
J Hepatol
, vol.43
, pp. 1060-1066
-
-
Suzuki, A.1
Lindor, K.2
St Saver, J.3
-
58
-
-
0025959287
-
Hepatic effects of dietary weight loss in morbidly obese subjects
-
Andersen T., Gluud C., Franzmann M., et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991, 12:224-229.
-
(1991)
J Hepatol
, vol.12
, pp. 224-229
-
-
Andersen, T.1
Gluud, C.2
Franzmann, M.3
-
59
-
-
19144372447
-
One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study
-
Huang M., Greenson J., Chao C., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005, 100:1072-1081.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1072-1081
-
-
Huang, M.1
Greenson, J.2
Chao, C.3
-
60
-
-
58949102847
-
Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial
-
Harrison S.A., Fecht W., Brunt E.M., et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 2009, 49:80-86.
-
(2009)
Hepatology
, vol.49
, pp. 80-86
-
-
Harrison, S.A.1
Fecht, W.2
Brunt, E.M.3
-
61
-
-
78651242073
-
BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons
-
Lopez-Nava G., Rubio M.A., Prados S., et al. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011, 21:5-9.
-
(2011)
Obes Surg
, vol.21
, pp. 5-9
-
-
Lopez-Nava, G.1
Rubio, M.A.2
Prados, S.3
-
62
-
-
70349763599
-
Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study
-
Genco A., Cipriano M., Materia A., et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc 2009, 23:1849-1853.
-
(2009)
Surg Endosc
, vol.23
, pp. 1849-1853
-
-
Genco, A.1
Cipriano, M.2
Materia, A.3
-
63
-
-
53849086533
-
Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients
-
Ricci G., Bersani G., Rossi A., et al. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 2008, 18:1438-1442.
-
(2008)
Obes Surg
, vol.18
, pp. 1438-1442
-
-
Ricci, G.1
Bersani, G.2
Rossi, A.3
-
64
-
-
77951623680
-
Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients
-
Forlano R., Ippolito A.M., Iacobellis A., et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010, 71:927-933.
-
(2010)
Gastrointest Endosc
, vol.71
, pp. 927-933
-
-
Forlano, R.1
Ippolito, A.M.2
Iacobellis, A.3
-
65
-
-
0026353971
-
Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel
-
NIH conference
-
Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991, 115:956-961. NIH conference.
-
(1991)
Ann Intern Med
, vol.115
, pp. 956-961
-
-
-
66
-
-
70349310620
-
-
American Society for Metabolic and Bariatric Surgery (2009), Accessed June 7, 2011
-
Fact sheet: metabolic & bariatric surgery American Society for Metabolic and Bariatric Surgery (2009), Accessed June 7, 2011. http://www.asbs.org.
-
Fact sheet: metabolic & bariatric surgery
-
-
-
67
-
-
52949106040
-
Gastric banding or bypass?. A systematic review comparing the two most popular bariatric procedures
-
Tice J.A., Karliner L., Walsh J., et al. Gastric banding or bypass?. A systematic review comparing the two most popular bariatric procedures. Am J Med 2008, 121:885-893.
-
(2008)
Am J Med
, vol.121
, pp. 885-893
-
-
Tice, J.A.1
Karliner, L.2
Walsh, J.3
-
68
-
-
26444467171
-
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome
-
Mattar S.G., Velcu L.M., Rabinovitz M., et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005, 242:610-617.
-
(2005)
Ann Surg
, vol.242
, pp. 610-617
-
-
Mattar, S.G.1
Velcu, L.M.2
Rabinovitz, M.3
-
69
-
-
32044451685
-
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
-
Clark J.M., Alkhuraishi A.R., Solga S.F., et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 2005, 13:1180-1186.
-
(2005)
Obes Res
, vol.13
, pp. 1180-1186
-
-
Clark, J.M.1
Alkhuraishi, A.R.2
Solga, S.F.3
-
70
-
-
2542546652
-
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
-
Dixon J.B., Bhathal P.S., Hughes N.R., et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004, 39:1647-1654.
-
(2004)
Hepatology
, vol.39
, pp. 1647-1654
-
-
Dixon, J.B.1
Bhathal, P.S.2
Hughes, N.R.3
-
71
-
-
33750571872
-
Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement
-
Dixon J.B., Bhathal P.S., O'Brien P.E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006, 16:1278-1286.
-
(2006)
Obes Surg
, vol.16
, pp. 1278-1286
-
-
Dixon, J.B.1
Bhathal, P.S.2
O'Brien, P.E.3
-
72
-
-
25844522508
-
Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity
-
Stratopoulos C., Papakonstantinou A., Terzis I., et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005, 15:1154-1160.
-
(2005)
Obes Surg
, vol.15
, pp. 1154-1160
-
-
Stratopoulos, C.1
Papakonstantinou, A.2
Terzis, I.3
-
73
-
-
0348047323
-
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
-
Kral J.G., Thung S.N., Biron S., et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004, 135:48-58.
-
(2004)
Surgery
, vol.135
, pp. 48-58
-
-
Kral, J.G.1
Thung, S.N.2
Biron, S.3
-
74
-
-
57149101692
-
Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis
-
Mummadi R.R., Kasturi K.S., Chennareddygari S., et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2008, 6:1396-1402.
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1396-1402
-
-
Mummadi, R.R.1
Kasturi, K.S.2
Chennareddygari, S.3
-
76
-
-
67650951419
-
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease
-
Mathurin P., Hollebecque A., Arnalsteen L., et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009, 137:532-540.
-
(2009)
Gastroenterology
, vol.137
, pp. 532-540
-
-
Mathurin, P.1
Hollebecque, A.2
Arnalsteen, L.3
-
77
-
-
79955767080
-
NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery-a prospective analysis
-
Ribeireiro T., Swain J., Sarr M., et al. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery-a prospective analysis. Obes Surg 2011, 21:310-315.
-
(2011)
Obes Surg
, vol.21
, pp. 310-315
-
-
Ribeireiro, T.1
Swain, J.2
Sarr, M.3
-
78
-
-
68049123594
-
Perioperative safety in the longitudinal assessment of bariatric surgery
-
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium
-
Flum D.R., Belle S.H., King W.C., et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009, 361:445-454. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.
-
(2009)
N Engl J Med
, vol.361
, pp. 445-454
-
-
Flum, D.R.1
Belle, S.H.2
King, W.C.3
-
79
-
-
46049092991
-
Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery
-
D'Albuquerque L.A., Gonzalez A.M., Wahle R.C., et al. Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery. Liver Transpl 2008, 14:881-885.
-
(2008)
Liver Transpl
, vol.14
, pp. 881-885
-
-
D'Albuquerque, L.A.1
Gonzalez, A.M.2
Wahle, R.C.3
-
80
-
-
16544390906
-
Hepatic decompensation after gastric bypass surgery for severe obesity
-
Cotler S.J., Vitello J.M., Guzman G., et al. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci 2004, 49:1563-1568.
-
(2004)
Dig Dis Sci
, vol.49
, pp. 1563-1568
-
-
Cotler, S.J.1
Vitello, J.M.2
Guzman, G.3
-
81
-
-
63349098164
-
Outcome after liver transplantation for NASH cirrhosis
-
Malik S.M., deVera M.E., Fontes P., et al. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009, 9:782-793.
-
(2009)
Am J Transplant
, vol.9
, pp. 782-793
-
-
Malik, S.M.1
deVera, M.E.2
Fontes, P.3
-
82
-
-
71249149460
-
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease
-
Bhagat V., Mindikoglu A.L., Nudo C.G., et al. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009, 15:1814-1820.
-
(2009)
Liver Transpl
, vol.15
, pp. 1814-1820
-
-
Bhagat, V.1
Mindikoglu, A.L.2
Nudo, C.G.3
-
83
-
-
71249126103
-
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis
-
Malik S.M., Devera M.E., Fontes P., et al. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl 2009, 15:1843-1851.
-
(2009)
Liver Transpl
, vol.15
, pp. 1843-1851
-
-
Malik, S.M.1
Devera, M.E.2
Fontes, P.3
-
84
-
-
77950639727
-
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
-
Yalamanchili K., Saadeh S., Klintmalm G.B., et al. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010, 16:431-439.
-
(2010)
Liver Transpl
, vol.16
, pp. 431-439
-
-
Yalamanchili, K.1
Saadeh, S.2
Klintmalm, G.B.3
-
85
-
-
79952758351
-
NAFLD recurrence in liver transplant recipients
-
Dureja P., Mellinger J., Agni R., et al. NAFLD recurrence in liver transplant recipients. Transplantation 2011, 91:684-689.
-
(2011)
Transplantation
, vol.91
, pp. 684-689
-
-
Dureja, P.1
Mellinger, J.2
Agni, R.3
-
86
-
-
79251488789
-
Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events
-
Laish I., Braun M., Mor E., et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011, 17:15-22.
-
(2011)
Liver Transpl
, vol.17
, pp. 15-22
-
-
Laish, I.1
Braun, M.2
Mor, E.3
-
87
-
-
71249127127
-
Posttransplant metabolic syndrome: an epidemic waiting to happen
-
Pagadala M., Dasarathy S., Eghtesad B., et al. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009, 15:1662-1670.
-
(2009)
Liver Transpl
, vol.15
, pp. 1662-1670
-
-
Pagadala, M.1
Dasarathy, S.2
Eghtesad, B.3
-
88
-
-
0141532275
-
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
-
Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003, 38:1008-1017.
-
(2003)
Hepatology
, vol.38
, pp. 1008-1017
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
-
89
-
-
70350662659
-
Metformin in patients with nonalcoholic fatty liver disease: a randomized, controlled trial
-
Haukeland J.W., Konopski Z., Eggesbo H.B., et al. Metformin in patients with nonalcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 2009, 44:853-860.
-
(2009)
Scand J Gastroenterol
, vol.44
, pp. 853-860
-
-
Haukeland, J.W.1
Konopski, Z.2
Eggesbo, H.B.3
|